Arjunan D, Grossman A, Singh H, Rai R, Bal A, Dutta P
JCEM Case Rep. 2024; 2(11):luae192.
PMID: 39465233
PMC: 11505447.
DOI: 10.1210/jcemcr/luae192.
Kumar S, Senapati S, Bhattacharya N, Bhattacharya A, Maurya S, Husain H
World J Clin Cases. 2023; 11(25):5840-5856.
PMID: 37727490
PMC: 10506040.
DOI: 10.12998/wjcc.v11.i25.5840.
Vinhosa Bastos Jr M, da Silva Caires I, Boschi Portella R, Nascimento Martins R, Reverdito R, Reverdito S
J Med Case Rep. 2023; 17(1):241.
PMID: 37308982
PMC: 10262407.
DOI: 10.1186/s13256-023-03963-5.
Svensson E, Muth A, Hedenstrom P, Ragnarsson O
Ann Gastroenterol. 2022; 35(4):434-440.
PMID: 35784630
PMC: 9210785.
DOI: 10.20524/aog.2022.0707.
Sharma A, Varshney P, Kasliwal R, Nagar A, Venkatatelikicherla K, Sarin S
Indian J Surg Oncol. 2022; 13(2):403-411.
PMID: 35782810
PMC: 9240150.
DOI: 10.1007/s13193-022-01534-6.
Identification and Validation of a New Peptide Targeting Pancreatic Beta Cells.
Wang Q, Zheng L, Wu K, Zhang B
Molecules. 2022; 27(7).
PMID: 35408679
PMC: 9000318.
DOI: 10.3390/molecules27072286.
Malignant insulinoma in a patient with hypoglycemia.
Wang T, Vu A, Mereu L, Ghosh M
CMAJ. 2022; 194(9):E332-E335.
PMID: 35256389
PMC: 9053995.
DOI: 10.1503/cmaj.211002.
A novel tool for visualization and detection of pancreatic neuroendocrine tumours. A 'fluorescent' world is calling for exploration?.
Sotiropoulou M, Mulita F, Verras G, Schizas D, Papalampros A, Tchabashvili L
Prz Menopauzalny. 2022; 20(4):207-210.
PMID: 35069073
PMC: 8764961.
DOI: 10.5114/pm.2021.110834.
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
Ito T, Masui T, Komoto I, Doi R, Osamura R, Sakurai A
J Gastroenterol. 2021; 56(11):1033-1044.
PMID: 34586495
PMC: 8531106.
DOI: 10.1007/s00535-021-01827-7.
A case report on a protracted course of a hidden insulinoma.
Mohamed Shah F, Mohamad A, Zainordin N, Eddy Warman N, Hatta S, Abdul Ghani R
Ann Med Surg (Lond). 2021; 64:102240.
PMID: 33868680
PMC: 8040123.
DOI: 10.1016/j.amsu.2021.102240.
Insulinoma in pregnancy (a case presentation and systematic review of the literature).
Dobrindt E, Mogl M, Goretzki P, Pratschke J, Dukaczewska A
Rare Tumors. 2021; 13:2036361320986647.
PMID: 33613925
PMC: 7874339.
DOI: 10.1177/2036361320986647.
Extrapancreatic insulinoma.
Garg R, Memon S, Patil V, Bandgar T
World J Nucl Med. 2020; 19(2):162-164.
PMID: 32939209
PMC: 7478312.
DOI: 10.4103/wjnm.WJNM_41_19.
Seeking the unseen: Localization and surgery for an occult sporadic insulinoma.
Subasinghe D, Gunatilake S, Dassanyake V, Garusinghe C, Ganewaththa E, Appuhamy C
Ann Hepatobiliary Pancreat Surg. 2020; 24(2):234-238.
PMID: 32457273
PMC: 7271113.
DOI: 10.14701/ahbps.2020.24.2.234.
Diagnostic value of ASVS for insulinoma localization: A systematic review and meta-analysis.
Wang H, Ba Y, Xing Q, Cai R
PLoS One. 2019; 14(11):e0224928.
PMID: 31743337
PMC: 6863549.
DOI: 10.1371/journal.pone.0224928.
The functioning side of the pancreas: a review on insulinomas.
Maggio I, Mollica V, Brighi N, Lamberti G, Manuzzi L, Ricci A
J Endocrinol Invest. 2019; 43(2):139-148.
PMID: 31368049
DOI: 10.1007/s40618-019-01091-w.
Rare malignant insulinoma with multiple liver metastases derived from ectopic pancreas: 3-year follow-up and literature review.
Liu Q, Duan J, Zheng Y, Luo J, Cai X, Tan H
Onco Targets Ther. 2018; 11:1813-1819.
PMID: 29662318
PMC: 5892612.
DOI: 10.2147/OTT.S154991.
Association of Insulinoma and Type 2 Diabetes Mellitus.
Ouleghzal H, Ziadi T, Menfaa M, Safi S
Int J Endocrinol Metab. 2017; 15(1):e39439.
PMID: 28835758
PMC: 5554613.
DOI: 10.5812/ijem.39439.
Severe Unresponsive Hypoglycemia Associated with Neuroendocrine Tumor of Unknown Primary Site - 18 Years after Rectal Cancer Surgery. Case Report.
Rusu O, Costea R, Popa C, Iliesiu A, Dumitru A, Becheanu G
Maedica (Bucur). 2017; 10(4):352-356.
PMID: 28465738
PMC: 5394448.
Arterial Calcium Stimulation with Hepatic Venous Sampling in the Localization Diagnosis of Endogenous Hyperinsulinism.
Moreno-Moreno P, Alhambra-Exposito M, Herrera-Martinez A, Palomares-Ortega R, Zurera-Tendero L, Espejo Herrero J
Int J Endocrinol. 2016; 2016:4581094.
PMID: 27795707
PMC: 5066019.
DOI: 10.1155/2016/4581094.
Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas.
Buishand F, Arkesteijn G, Feenstra L, Oorsprong C, Mestemaker M, Starke A
Stem Cells Dev. 2016; 25(11):826-35.
PMID: 27049037
PMC: 4892226.
DOI: 10.1089/scd.2016.0032.